We presented basic and convincing evidence in the present work to propose that PRMT1 is the upstream regulator of CFLAR in hepatocytes, which promotes its ubiquitination degradation through direct methylation of CFLAR, thus inhibiting the CFLAR-JNK axis and ultimately promoting the occurrence and development of NAFLD. This evidence concerns the gene PRMT1 and metabolic dysfunction-associated steatotic liver disease.